• Thu, November 11, 2021
Elliot Wilbur Upgraded (ADMA) to Strong Buy and Held Target at $5 on, Nov 11th, 2021
Elliot Wilbur of Raymond James, Upgraded "ADMA Biologics, Inc." (ADMA) to Strong Buy and Held Target at $5 on, Nov 11th, 2021.
Elliot has made no other calls on ADMA in the last 4 months.
There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Elliot's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Elliot
- Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $4.5 on, Tuesday, November 9th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $6 on, Thursday, August 12th, 2021
Like: 👍
